ArticleCase reports in cardiology2025
Persistent Pulmonary Hypertension in Corrected Congenital Left Circumflex Artery to Coronary Sinus Fistula: A Case Report and Literature Review.
Article in Case reports in cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Coronary artery fistulas (CAFs) are rare congenital anomalies, with the left circumflex artery to coronary sinus (LCx-CS) fistula representing an uncommon subtype. Pulmonary hypertension (PHTN) may arise as a consequence of large, unrepaired CAFs. While most patients experience improvement following surgical repair, there are instances where PHTN persists, necessitating ongoing monitoring and pharmacological intervention. Case Description: We present the case of a middle-aged woman with no significant medical history who presented with dyspnea. She was found to have PHTN secondary to a large LCx-CS fistula. She underwent surgical ligation of the fistula. Postoperatively, the patient remained symptomatic, with elevated pulmonary arterial pressure persisting, prompting the initiation of triple therapy comprising macitentan, selexipag, and sildenafil. This therapeutic regimen significantly resolved her symptoms and improved her functional capacities. Discussion: This case highlights the hemodynamic implications associated with a long-standing LCx-CS fistula. Although congenital, such anomalies can remain asymptomatic for extended periods. The most likely hypothesis is that a large chronic fistula can cause irreversible histopathological changes to the pulmonary microvasculature, resulting in a "point of no return" and leading to persistent symptoms even after anatomical correction. In most reported scenarios, the surgical or interventional correction of CAF results in symptom resolution and hemodynamic improvement. However, the described case illustrates an atypical presentation, revealing the potential for sustained elevation of pulmonary arterial pressures. Consequently, this necessitates ongoing pharmacological management. Conclusion: While LCx-CS fistulas are infrequent and often asymptomatic, chronic fistula cases may result in various complications and symptomatic presentations. The case illustrates a rare case of persistent PHTN in a corrected LCx-CS fistula. Thorough follow-up, early diagnosis, and timely interventions, complemented by pharmacotherapy when necessary, are essential in managing these complex clinical scenarios.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.